Skip to content

US · VIVS

VivoSim Labs, Inc.

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
San Diego, CA 92121
Website
vivosim.ai

Price · as of 2026-09-04

$0.28

Market cap 933.7K

Price history

Weekly OHLC price history for VIVS, USD per share
WeekOpenHighLowCloseVolume
Apr 14, 2025 – Apr 17, 2025$1.65$1.77$1.56$1.72
Apr 21, 2025 – Apr 25, 2025$1.68$2.28$1.56$1.860
Apr 28, 2025 – May 2, 2025$1.82$2.14$1.63$2.000
May 5, 2025 – May 9, 2025$1.95$2.09$1.75$1.900
May 12, 2025 – May 16, 2025$1.98$2.20$1.79$2.070
May 19, 2025 – May 23, 2025$2.00$2.06$1.91$1.980
May 26, 2025 – May 30, 2025$1.96$2.06$1.68$1.800
Jun 2, 2025 – Jun 6, 2025$1.74$1.90$1.68$1.840
Jun 9, 2025 – Jun 13, 2025$1.79$1.87$1.61$1.610
Jun 16, 2025 – Jun 20, 2025$1.60$1.61$1.41$1.460
Jun 23, 2025 – Jun 27, 2025$1.45$1.61$1.42$1.470
Jun 30, 2025 – Jul 3, 2025$1.46$1.58$1.42$1.570
Jul 7, 2025 – Jul 11, 2025$1.58$2.08$1.58$1.940
Jul 14, 2025 – Jul 18, 2025$1.93$2.03$1.75$1.890
Jul 21, 2025 – Jul 25, 2025$1.91$2.35$1.90$2.240
Jul 28, 2025 – Aug 1, 2025$2.24$2.37$1.75$1.850
Aug 4, 2025 – Aug 8, 2025$1.85$1.99$1.73$1.750
Aug 11, 2025 – Aug 15, 2025$1.79$1.89$1.71$1.770
Aug 18, 2025 – Aug 22, 2025$1.77$2.17$1.72$2.110
Aug 25, 2025 – Aug 29, 2025$2.07$2.99$1.76$2.440
Sep 1, 2025 – Sep 5, 2025$2.40$3.10$2.06$2.510
Sep 8, 2025 – Sep 12, 2025$2.55$4.22$2.29$4.190
Sep 15, 2025 – Sep 19, 2025$4.23$5.30$3.29$4.150
Sep 22, 2025 – Sep 26, 2025$4.08$4.11$3.05$3.210
Sep 29, 2025 – Oct 3, 2025$3.21$3.48$2.81$3.400
Oct 6, 2025 – Oct 10, 2025$3.28$3.54$2.90$3.040
Oct 13, 2025 – Oct 17, 2025$3.10$3.15$2.50$2.560
Oct 20, 2025 – Oct 24, 2025$2.55$2.79$2.16$2.330
Oct 27, 2025 – Oct 31, 2025$2.44$3.20$2.14$2.700
Nov 3, 2025 – Nov 7, 2025$2.52$2.70$2.03$2.180
Nov 10, 2025 – Nov 14, 2025$2.15$2.46$2.02$2.170
Nov 17, 2025 – Nov 21, 2025$2.21$2.47$2.05$2.170
Nov 24, 2025 – Nov 28, 2025$2.19$2.35$2.12$2.240
Dec 1, 2025 – Dec 5, 2025$2.18$2.40$2.11$2.320
Dec 8, 2025 – Dec 12, 2025$2.39$2.51$2.12$2.220
Dec 15, 2025 – Dec 19, 2025$2.13$2.32$1.82$1.980
Dec 22, 2025 – Dec 26, 2025$1.96$2.08$1.84$2.010
Dec 29, 2025 – Jan 2, 2026$1.95$1.95$1.74$1.880
Jan 5, 2026 – Jan 9, 2026$1.87$2.29$1.87$1.920
Jan 12, 2026 – Jan 16, 2026$2.00$2.18$1.92$2.090
Jan 19, 2026 – Jan 23, 2026$2.03$2.16$1.90$1.900
Jan 26, 2026 – Jan 30, 2026$1.90$3.40$1.70$2.920
Feb 2, 2026 – Feb 6, 2026$2.77$2.89$2.25$2.280
Feb 9, 2026 – Feb 13, 2026$2.27$2.32$1.81$2.000
Feb 16, 2026 – Feb 20, 2026$1.96$2.17$1.86$2.020
Feb 23, 2026 – Feb 27, 2026$2.01$2.28$1.86$2.170
Mar 2, 2026 – Mar 6, 2026$2.01$2.21$1.82$1.830
Mar 9, 2026 – Mar 13, 2026$1.82$1.96$1.80$1.800
Mar 16, 2026 – Mar 20, 2026$1.80$1.88$1.65$1.680
Mar 23, 2026 – Mar 27, 2026$1.68$1.79$1.55$1.620
Mar 30, 2026 – Apr 2, 2026$1.56$1.71$1.25$1.690
Apr 6, 2026 – Apr 10, 2026$1.65$1.87$1.43$1.450
Apr 13, 2026 – Apr 17, 2026$1.44$1.89$1.44$1.610
Apr 20, 2026 – Apr 24, 2026$1.55$1.61$1.42$1.460
Apr 27, 2026 – May 1, 2026$1.52$1.67$1.36$1.440
May 4, 2026 – May 8, 2026$1.42$1.48$1.38$1.390
May 11, 2026 – May 15, 2026$1.39$1.41$1.27$1.290
May 18, 2026 – May 22, 2026$1.28$1.38$1.22$1.360
May 25, 2026 – May 29, 2026$1.35$1.35$1.25$1.310
Jun 1, 2026 – Jun 5, 2026$1.29$1.35$1.18$1.200
Jun 8, 2026 – Jun 12, 2026$1.21$1.26$1.13$1.140
Jun 15, 2026 – Jun 18, 2026$1.17$1.25$1.10$1.100
Jun 22, 2026 – Jun 26, 2026$1.15$1.21$1.02$1.030
Jun 29, 2026 – Jul 2, 2026$1.12$1.12$0.95$0.980
Jul 6, 2026 – Jul 10, 2026$0.99$1.02$0.78$0.880
Jul 13, 2026 – Jul 17, 2026$0.89$1.57$0.52$0.580
Jul 20, 2026 – Jul 24, 2026$0.56$0.58$0.41$0.420
Jul 27, 2026 – Jul 31, 2026$0.39$0.42$0.31$0.340
Aug 3, 2026 – Aug 7, 2026$0.34$0.58$0.31$0.470
Aug 10, 2026 – Aug 14, 2026$0.41$0.42$0.32$0.320
Aug 17, 2026 – Aug 21, 2026$0.32$0.33$0.26$0.290
Aug 24, 2026 – Aug 28, 2026$0.28$0.30$0.28$0.290
Aug 31, 2026 – Sep 4, 2026$0.29$0.30$0.27$0.280

Valuation

MetricValueUpside
IC Value$0.48+73%
P/E-0.22
P/B-2.83
P/S23.71
EV/EBITDA0.11
PEG-0.10
P/TBV-2.83

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for VIVS, USD per share
YearPriceAIICGraham-DoddGraham Formula
2012
2013$960.00
2014$1,852.80$406.94
2015$1,209.60
2016$744.00$150.31
2017$645.60$136.47
2018$331.20$68.59
2019$110.40$270.15
2020$160.80$255.09
2021$103.08
2022$25.08
2023$20.88$21.39
2024$11.52$8.64
2025$1.84$150.54
2026$1.20$40.98

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About VivoSim Labs, Inc.

        VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

        CEO
        Keith Murphy
        Employees
        15
        Beta
        1.40

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for VIVS: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        VIVSVivoSim Labs, Inc.$0.47933.7K$40.98+8,656%-0.22-2.8323.710.11-0.10-2.83100.00%-8567.94%-10567.18%-294.75%404.12%-125.64%-0.41-935.332.382.180.34214.71%-9.03%14.28%-348.58%-3.89389.88%0.00%0.00%0.00%0.130.14-11.23-71.63
        CYCNCyclerion Therapeutics, I…$3.5716.71M$39.93+1,018%-1.330.512.25-0.410.51100.00%-239.78%-170.11%-39.34%-86.77%-36.07%0.005.154.710.92-9.92%3.70%-23.52%-70.87%-3.68-57.82%0.00%0.00%2.95%-0.29-0.430.69-35.87
        KTTAPasithea Therapeutics Cor…$0.513.77M0.000.102.450.110.00%0.00%0.00%-58363.21%-526.68%-53542.34%0.0011.3511.092.73-77.07%109150.95%-263840.10%-3058.22-384116.60%0.00%0.00%836.65%2.370.00-1.06
        PLRZPolyrizon Ltd.$11.5912.98M-6.901.10-1.821.250.00%0.00%0.00%-25.38%-109.12%-24.72%0.00-1.9929.0327.700.22-98.46%295.38%-19.72%-10.22-79.19%0.00%0.00%0.00%-1.72-2.3630.33
        PMCBPharmaCyte Biotech, Inc.$0.594.01M-0.280.170.000.170.00%0.00%0.00%-45.61%-32.58%-38.12%0.0045.2845.160.00-186.83%73.02%-93.19%-6.24-31.65%4.45%-1.30%73.77%5.956.12-2.28
        QNRXQuoin Pharmaceuticals, Lt…$4.799.62M-0.760.92242.35-0.030.00%0.00%0.00%-142.71%0.86%-88.26%0.003.61688.33243.12-84.10%72.34%-112.13%-2.440.71%0.00%0.00%31585.93%233.63281.07-5.66
        RADXRadiopharm Theranostics L…$2.803.61M$50.02+1,686%1.2615.53-0.72-31.651.08%-1050.63%-1055.27%0.00%-302.69%0.00%0.00-584.592.672.650.76-85.33%1114.27%59.50%-64.96%-2.45-290.58%0.00%18.69%-0.72-0.747.51-2.65
        TCRTAlaunos Therapeutics, Inc…$1.994.86M$91.89+4,518%-1.542.991285.92-1.212.99-27160.00%-84500.00%-83520.00%-198.10%-485.63%-145.99%0.002.451.710.33-24.66%-50.00%-40.31%-46.15%-3.53-341.03%0.00%0.00%4.57%-1.19-1.701008.92-435.92
        XTLBXTL Biopharmaceuticals Lt…$2.9427.82M$1.34-54%-0.14-3.97-1.51-0.03-3.970.00%0.00%0.00%-269.02%-78.49%-159.91%-1.06-241.140.400.34-0.26566.67%-100.00%-38.70%-101.53%-2.44-47.66%0.00%0.00%0.00%-0.67-1.11-1430.85

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.48 ÷ $0.28) − 1 = +72.54% (IC, example).